Pro-inflammatory signalling PRRopels cisplatin-induced toxicity

IK Domingo, A Latif, AP Bhavsar - International journal of molecular …, 2022 - mdpi.com
Cisplatin is a platinum-based chemotherapeutic that has long since been effective against a
variety of solid-cancers, substantially improving the five-year survival rates for cancer …

Oxidative damage as a fundament of systemic toxicities induced by cisplatin—the crucial limitation or potential therapeutic target?

JS Katanić Stanković, D Selaković, G Rosić - International journal of …, 2023 - mdpi.com
Cisplatin, an inorganic complex of platinum, is a chemotherapeutic drug that has been used
for 45 years. Despite the progress of pharmaceutical sciences and medicine and the …

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

T Karasawa, PS Steyger - Toxicology letters, 2015 - Elsevier
Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and
ototoxic side-effects remain major clinical limitations. Recent studies have improved our …

Cisplatin nephrotoxicity: new insights and therapeutic implications

C Tang, MJ Livingston, R Safirstein… - Nature Reviews …, 2023 - nature.com
Cisplatin is an effective chemotherapeutic agent for various solid tumours, but its use is
limited by adverse effects in normal tissues. In particular, cisplatin is nephrotoxic and can …

Subcellular targets of cisplatin cytotoxicity: an integrated view

SM Sancho-Martínez, L Prieto-García, M Prieto… - Pharmacology & …, 2012 - Elsevier
Cisplatin is a chemotherapeutic drug widely used against a variety of cancers. Its clinical
utility is severely limited by its toxicity, which mainly affects, but is not limited to, the inner ear …

Cisplatin-induced ototoxicity: updates on molecular targets

E Gentilin, E Simoni, M Candito, D Cazzador… - Trends in molecular …, 2019 - cell.com
Cis-diamminedichloridoplatinum (II)(cisplatin) is a chemotherapeutic drug currently
prescribed for the treatment of many types of human cancer, but its use is associated with …

Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy

S Jaiman, AK Sharma, K Singh, D Khanna - European journal of clinical …, 2013 - Springer
Context Cisplatin, a coordination platinum complex, is used as a potential anti-neoplastic
agent, having well recognized DNA-damaging property that triggers cell-cycle arrest and cell …

Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies

S Mirzaei, K Hushmandi, A Zabolian, H Saleki… - Molecules, 2021 - mdpi.com
The failure of chemotherapy is a major challenge nowadays, and in order to ensure effective
treatment of cancer patients, it is of great importance to reveal the molecular pathways and …

Cisplatin-associated nephrotoxicity and pathological events

T Taguchi, A Nazneen, MR Abid… - … Stress Responses in …, 2005 - karger.com
Cisplatin (cis-diamminedichloroplatinum (II)) is an effective chemotherapeutic agent, and is
successfully used in the treatment of a wide range of tumors. Despite its effectiveness as an …

Can cisplatin therapy be improved? Pathways that can be targeted

R Ali, M Aouida, A Alhaj Sulaiman… - International Journal of …, 2022 - mdpi.com
Cisplatin (cis-diamminedichloroplatinum (II)) is the oldest known chemotherapeutic agent.
Since the identification of its anti-tumour activity, it earned a remarkable place as a treatment …